Esperion Therapeutics
ESPR
#6169
Rank
A$1.33 B
Marketcap
A$5.62
Share price
-1.58%
Change (1 day)
8.44%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): A-$0.85

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is A-$0.81. In 2024 the company made an earnings per share (EPS) of A-$0.35 an increase over its 2023 EPS that were of A-$3.19.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.85144.47%
2024A-$0.35-89.15%
2023A-$3.19-40.28%
2022A-$5.34-62.87%
2021A-$14.3980.38%
2020A-$7.9850.14%
2019A-$5.31-53.18%
2018A-$11.357.41%
2017A-$10.57110.81%
2016A-$5.0147.35%
2015A-$3.400.89%
2014A-$3.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
A-$8.94 1,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$4.09-603.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$2.59-418.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$65.40-8,144.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A-$0.17-79.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A-$0.29-64.81%๐Ÿ‡บ๐Ÿ‡ธ USA